"Ins" and "Outs" of mesenchymal stem cell osteogenesis in regenerative medicine
- PMID: 24772237
- PMCID: PMC3999785
- DOI: 10.4252/wjsc.v6.i2.94
"Ins" and "Outs" of mesenchymal stem cell osteogenesis in regenerative medicine
Abstract
Repair and regeneration of bone requires mesenchymal stem cells that by self-renewal, are able to generate a critical mass of cells with the ability to differentiate into osteoblasts that can produce bone protein matrix (osteoid) and enable its mineralization. The number of human mesenchymal stem cells (hMSCs) diminishes with age and ex vivo replication of hMSCs has limited potential. While propagating hMSCs under hypoxic conditions may maintain their ability to self-renew, the strategy of using human telomerase reverse transcriptase (hTERT) to allow for hMSCs to prolong their replicative lifespan is an attractive means of ensuring a critical mass of cells with the potential to differentiate into various mesodermal structural tissues including bone. However, this strategy must be tempered by the oncogenic potential of TERT-transformed cells, or their ability to enhance already established cancers, the unknown differentiating potential of high population doubling hMSCs and the source of hMSCs (e.g., bone marrow, adipose-derived, muscle-derived, umbilical cord blood, etc.) that may provide peculiarities to self-renewal, differentiation, and physiologic function that may differ from non-transformed native cells. Tissue engineering approaches to use hMSCs to repair bone defects utilize the growth of hMSCs on three-dimensional scaffolds that can either be a base on which hMSCs can attach and grow or as a means of sequestering growth factors to assist in the chemoattraction and differentiation of native hMSCs. The use of whole native extracellular matrix (ECM) produced by hMSCs, rather than individual ECM components, appear to be advantageous in not only being utilized as a three-dimensional attachment base but also in appropriate orientation of cells and their differentiation through the growth factors that native ECM harbor or in simulating growth factor motifs. The origin of native ECM, whether from hMSCs from young or old individuals is a critical factor in "rejuvenating" hMSCs from older individuals grown on ECM from younger individuals.
Keywords: Differentiation; Extracellular matrix; Mesenchymal stem cell; Osteogenesis; Proliferation; Regenerative medicine; Telomerase reverse transcriptase; Tissue engineering.
Figures
Similar articles
-
Proliferation and osteogenesis of immortalized bone marrow-derived mesenchymal stem cells in porous polylactic glycolic acid scaffolds under perfusion culture.J Biomed Mater Res A. 2010 Mar 1;92(3):817-29. doi: 10.1002/jbm.a.32378. J Biomed Mater Res A. 2010. PMID: 19280635
-
Bone repair by transplantation of hTERT-immortalized human mesenchymal stem cells in mice.Transplantation. 2009 Aug 15;88(3):346-53. doi: 10.1097/TP.0b013e3181ae5ba2. Transplantation. 2009. PMID: 19667936
-
Effects of Fiber Alignment and Coculture with Endothelial Cells on Osteogenic Differentiation of Mesenchymal Stromal Cells.Tissue Eng Part C Methods. 2020 Jan;26(1):11-22. doi: 10.1089/ten.TEC.2019.0232. Epub 2019 Dec 27. Tissue Eng Part C Methods. 2020. PMID: 31774033
-
[Safety evaluation of tissue engineered medical devices using normal human mesenchymal stem cells].Yakugaku Zasshi. 2007 May;127(5):851-6. doi: 10.1248/yakushi.127.851. Yakugaku Zasshi. 2007. PMID: 17473528 Review. Japanese.
-
Age associated communication between cells and matrix: a potential impact on stem cell-based tissue regeneration strategies.Organogenesis. 2014;10(3):289-98. doi: 10.4161/15476278.2014.970089. Organogenesis. 2014. PMID: 25482504 Free PMC article. Review.
Cited by
-
Nanoengineered biomimetic hydrogels for guiding human stem cell osteogenesis in three dimensional microenvironments.J Mater Chem B. 2016 May 28;4(20):3544-3554. doi: 10.1039/C5TB02745D. Epub 2016 Feb 4. J Mater Chem B. 2016. PMID: 27525102 Free PMC article.
-
Molecules Inducing Dental Stem Cells Differentiation and Bone Regeneration: State of the Art.Int J Mol Sci. 2023 Jun 8;24(12):9897. doi: 10.3390/ijms24129897. Int J Mol Sci. 2023. PMID: 37373044 Free PMC article. Review.
-
Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues.Stem Cell Res Ther. 2016 Aug 25;7(1):122. doi: 10.1186/s13287-016-0383-3. Stem Cell Res Ther. 2016. PMID: 27557940 Free PMC article.
-
Enhancement of osteogenic differentiation of adipose-derived stem cells by PRP modified nanofibrous scaffold.Cytotechnology. 2018 Dec;70(6):1487-1498. doi: 10.1007/s10616-018-0226-4. Epub 2018 Aug 6. Cytotechnology. 2018. PMID: 30083791 Free PMC article.
-
Craniofacial Osteosarcoma-Pilot Study on the Expression of Osteobiologic Characteristics and Hypothesis on Metastasis.Front Oncol. 2020 Jun 23;10:745. doi: 10.3389/fonc.2020.00745. eCollection 2020. Front Oncol. 2020. PMID: 32656074 Free PMC article.
References
-
- Rando TA. Stem cells, ageing and the quest for immortality. Nature. 2006;441:1080–1086. - PubMed
-
- Jones DL, Wagers AJ. No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol. 2008;9:11–21. - PubMed
-
- Bianco P. Minireview: The stem cell next door: skeletal and hematopoietic stem cell “niches” in bone. Endocrinology. 2011;152:2957–2962. - PubMed
-
- Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726–736. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources